Eli Lilly's Groundbreaking Obesity Drug Shows Record-Breaking Weight Loss Results

Eli Lilly's experimental retatrutide helps patients lose up to 24% body weight in trials, setting new standards for obesity treatment but with notable side effects and dropout rates.